Claims 2024: What’s Happening and What You Need to Know
In this on-demand webinar recorded live on December 11, 2024, Sonia Valdes, Andy Hall, and Lauren Hulbert from the Medmarc Claims Department, along with guest Jeff Nicoson from Leitner, Williams, Dooley & Napolitan, discussed the life sciences claims environment in 2024. The panel covered supply chain management, challenges related to international supply chains, and the implications of the Loper Bright case. They also examined the effects of recent legal rulings, including the Zantac decision, and how political and advocacy group influences might impact FDA decisions. Lastly, the discussion ended with a crystal ball outlook of uncertainty which included the potential effects of litigation financing on plaintiff attorneys and mass torts and was optimistic about the use of AI in detecting fraud and inconsistencies in clinical trials.
00:00 - Introduction of the Presenters
01:50 - What You Need to Know About Doing Business Across Borders
15:08 - Supply Chain Management - Other Issues & What Can We Do?
20:28 - What is Loper Bright?
28:38 - Important 2024 Verdicts and Decisions
38:26 - Acetaminophen ADHD/Autism lawsuits
42:19 - Zantac Decisions
47:45 - Duty to Innovate
54:00 - Apex Doctrine
58:30 - Crystal ball -What is on the horizon in 2025?
01:06:24 - Closing
Presenters:
Sonia Valdes, Andy Hall , Lauren Hulbert | Medmarc Claims Department
Along with guest
Jeff Nicoson | Equity Member| Leitner, Williams, Dooley & Napolitan, PLLC